The North America Sequencing Reagents Market would witness market growth of 16.9% CAGR during the forecast period (2024-2031).
The US market dominated the North America Sequencing Reagents Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $7,554.6 million by 2031. Canada market is experiencing a CAGR of 19.2% during (2024 - 2031). Additionally, The Mexico market would exhibit a CAGR of 18.4% during (2024 - 2031).
Beyond healthcare, sequencing technologies have revolutionized agriculture, environmental sciences, and evolutionary biology research. In agriculture, genomic sequencing has enabled the identification of genes linked to desirable traits such as drought resistance, pest tolerance, and higher yields.
Additionally, drought-resistant rice varieties and pest-resistant maize and wheat strains have been developed using insights from sequencing, contributing to sustainable farming and addressing food security challenges exacerbated by climate change. These advancements rely on sequencing reagents to ensure the precision and reliability of genetic data, which is crucial for breeding programs and genetic engineering efforts.
Oncology is a significant application of sequencing technologies across North America, driving substantial reagent demand. In the U.S., initiatives like the Cancer Moonshot have allocated billions of dollars to accelerate cancer research, emphasizing the role of genomic sequencing in understanding tumor biology and guiding targeted therapies. Canada’s investments in cancer genomics, such as through the Ontario Institute for Cancer Research, support advanced studies in identifying biomarkers and genetic predispositions. In Mexico, oncology research has begun to adopt genomic sequencing to address increasing cancer rates, focusing on early diagnosis and precision treatment. These efforts highlight sequencing reagents' critical role in enabling accurate and reliable results in cancer research and treatment across the region.
Free Valuable Insights: The Sequencing Reagents Market is Predict to reach USD 24.45 Billion by 2031, at a CAGR of 17.5%
Based on Type, the market is segmented into Sequencing Kits, Library Kits, Control Kits, Template Kits, and Other Type. Based on Technology, the market is segmented into Next-Generation Sequencing, Third Generation Sequencing, and Sanger Sequencing. Based on Application, the market is segmented into Oncology, Reproductive Health, Clinical Investigation, Agrigenomics & Forensics, Consumer Genomics, and Other Application. Based on End Use, the market is segmented into Academic Research, Clinical Research, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, and Other End Use. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
By Type
By Technology
By Application
By End Use
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 